Supriya Lifescience Limited
Supriya Lifescience Limited, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions. Founded in 1997, the company has established itself as a leader in the production of active pharmaceutical ingredients (APIs) and intermediates, catering to both domestic and international markets. With a strong focus on quality and innovation, Supriya Lifescience offers a diverse range of products, including anti-allergic, anti-inflammatory, and anti-viral APIs. Their commitment to research and development has led to significant advancements, positioning them as a trusted supplier in the global pharmaceutical landscape. Notably, the company has achieved several milestones, including regulatory approvals from major international health authorities, further solidifying its reputation for excellence in the industry.
DitchCarbon Score
How does Supriya Lifescience Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Supriya Lifescience Limited's score of 21 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Supriya Lifescience Limited's reported carbon emissions
In 2023, Supriya Lifescience Limited reported total carbon emissions of approximately 11,446,280 kg CO2e, comprising 451,010 kg CO2e from Scope 1 and 10,995,310 kg CO2e from Scope 2 emissions. This data reflects their operational impact and is crucial for understanding their carbon footprint. The company has also disclosed emissions for 2022, which were about 11,950,976 kg CO2e, with Scope 1 emissions at 490,206 kg CO2e and Scope 2 emissions at 11,450,770 kg CO2e. Despite these figures, Supriya Lifescience Limited has not set specific reduction targets or initiatives, nor do they participate in the Science Based Targets initiative (SBTi). Their emissions data is not cascaded from any parent organization, indicating that the reported figures are solely from their own operations. The company’s emissions intensity per rupee of turnover has been reported as 0.00005627 in 2023 and 0.00005703 in 2022, indicating a slight increase in emissions relative to revenue. This highlights the need for ongoing monitoring and potential strategies to enhance sustainability practices. Overall, while Supriya Lifescience Limited has made strides in transparency regarding their emissions, the absence of reduction targets suggests an opportunity for further commitment to climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 490,206 | 000,000 |
| Scope 2 | 11,450,770 | 00,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Supriya Lifescience Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
